We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Diagnostic Test for Congenital Syphilis Could Enable Immediate Treatment

By LabMedica International staff writers
Posted on 15 Sep 2023

Newborns with congenital syphilis may suffer from issues like bone damage, severe anemia, enlarged liver and spleen, jaundice, nerve issues leading to blindness or hearing loss, meningitis, or skin conditions. More...

The severity of these health issues in the baby largely depends on whether the mother has received timely treatment for syphilis. At present, there are no sensitive diagnostic tests to confirm if a newborn has congenital syphilis. The current diagnostic approach is based on whether the mother has been treated for syphilis or if the baby shows any symptoms of the disease, along with abnormally high syphilis serology labs. As a result, doctors are forced to go through a checklist to assess if the mother has the infection and monitor the newborn for months to establish their infection status. Now, a molecular diagnostic test being developed for the detection of congenital syphilis could enable physicians to begin immediate treatment for newborns.

Researchers from UTHealth Houston (Houston, TX, USA) are working on creating a molecular diagnostic test that can quickly identify congenital syphilis, enabling immediate treatment for the affected newborns. The team is also planning a multicenter study that will examine the neurodevelopmental outcomes in babies born with the disease. This is particularly important as 60% of untreated babies born with syphilis suffer from neurodevelopmental issues.

“Our goal is to create a test for syphilis that is effective, so we can do immediate treatment,” said Irene Stafford, MD, at UTHealth Houston who is the principal investigator. “This test could be an incredible step in treating and diagnosing congenital syphilis.”

Related Links:
UTHealth Houston 


New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
Laboratory Software
ArtelWare
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.